Dipexium Pharmaceuticals' IPO

Dipexium Pharmaceuticals raised a round of funding on March 13, 2014. Investors include Public.

Dipexium Pharmaceuticals (NASDAQ: DPRX) is a late-stage pharmaceutical company focused on the development and commercialization of Locilex (pexiganan cream 1%), a broad-spectrum, topical antibiotic pe…

Articles about Dipexium Pharmaceuticals' IPO: